Morepen Laboratories Limited — Others, 04-12-2024: Others

Morepen Laboratories Limited has stated that its wholly-owned subsidiaries, Dr. Morepen Limited and Morepen RX Limited, will be entering a new Distribution Agreement with Generica India Limited (GIL), effective December 1, 2024. This replaces the previous agreement with Morepen RX, aimed at enhancing product penetration and consolidating the Dr. Morepen brand. The agreement allows GIL to distribute various OTC products for DML, with no impact expected on management or operational control. This realignment could indicate a strategic shift to improve market dynamics, presenting a positive outlook for investors focused on brand growth.